Sulter Geert, Elting Jan Willem, Maurits Natasha, Luijckx Gert Jan, De Keyser Jacques
Department of Neurology, Academisch Ziekenhuis Groningen, The Netherlands.
Cerebrovasc Dis. 2004;17(2-3):118-22. doi: 10.1159/000075779. Epub 2003 Dec 23.
Because elevated body temperature (BT) in acute ischemic stroke is associated with poor outcome, it is currently recommended to maintain normothermia with antipyretics. Whether this can be achieved by the administration of acetylsalicylic acid (ASA) or acetaminophen is uncertain.
Over a period of 9 months, patients admitted with acute hemiparetic ischemic stroke were monitored for BT in the first 48 h. When BT rose >37.5 degrees C, patients were treated with either ASA 500 mg intravenously or acetaminophen suppository 1,000 mg. When 6 h later the BT was still or again >37.5 degrees C, patients were further treated with acetaminophen suppository 1,000 mg up to 4 times a day. Primary outcome measure was normothermia (BT </=37.5 degrees C) within respectively 1 and 3 h after intervention. Secondary outcome parameters were any decrease in BT and the mean decrease in BT.
Of a total of 132 patients, 63 (48%) developed a BT >37.5 degrees C. The effects of 43 injections of ASA and 89 administrations of acetaminophen were studied. After 1 h, treatment with acetaminophen produced both significantly more reductions in BT and normothermia (respectively in 60 and 20%) than treatment with ASA (respectively in 37 and 5%). At 3 h, both interventions had a similar effect, with normothermia being achieved in only 37-38%. Fever (>38.0 degrees C) and evidence of an infection were related to unresponsiveness to treatment.
In the majority of patients with acute ischemic stroke, ASA and acetaminophen are insufficient for reducing an elevated BT to a state of normothermia.
由于急性缺血性卒中患者体温升高与预后不良相关,目前建议使用退烧药维持正常体温。但使用乙酰水杨酸(ASA)或对乙酰氨基酚能否达到这一目的尚不确定。
在9个月的时间里,对急性偏瘫性缺血性卒中患者入院后的前48小时进行体温监测。当体温升至>37.5摄氏度时,患者接受静脉注射500毫克ASA或1000毫克对乙酰氨基酚栓剂治疗。6小时后若体温仍或再次>37.5摄氏度,则患者进一步接受1000毫克对乙酰氨基酚栓剂治疗,每日最多4次。主要结局指标为干预后1小时和3小时内达到正常体温(体温≤37.5摄氏度)。次要结局参数为体温的任何下降以及体温的平均下降。
总共132例患者中,63例(48%)体温>37.5摄氏度。研究了43次ASA注射和89次对乙酰氨基酚给药的效果。1小时后,与ASA治疗(体温下降和达到正常体温的比例分别为37%和5%)相比,对乙酰氨基酚治疗使体温下降和达到正常体温的比例显著更高(分别为60%和20%)。3小时时,两种干预措施效果相似,达到正常体温的比例仅为37%-38%。发热(>38.0摄氏度)和感染迹象与治疗无反应相关。
在大多数急性缺血性卒中患者中,ASA和对乙酰氨基酚不足以将升高的体温降至正常体温状态。